ID

29711

Descrizione

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response; ODM derived from: https://clinicaltrials.gov/show/NCT00758043

collegamento

https://clinicaltrials.gov/show/NCT00758043

Keywords

  1. 15/04/18 15/04/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

15 aprile 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis C NCT00758043

Eligibility Hepatitis C NCT00758043

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
has not received any previous treatment with any approved or investigational drug or drug regimen for the treatment of hepatitis c
Descrizione

Hepatitis C untreated | Pharmaceutical Preparations Absent | Investigational New Drugs Absent | Pharmacotherapy Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0013230
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0013216
UMLS CUI [4,2]
C0332197
male and female subjects, 18 to 70 years of age, inclusive
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
genotype 1, chronic hepatitis c with detectable hcv rna.
Descrizione

Hepatitis C virus genotype determination | Hepatitis C, Chronic | HCV RNA Detectable

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1533728
UMLS CUI [2]
C0524910
UMLS CUI [3,1]
C0369335
UMLS CUI [3,2]
C3830527
screening laboratory values, tests, and physical exam within acceptable ranges
Descrizione

Laboratory Results Acceptable | Laboratory Procedures Acceptable | Physical Examination Acceptable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C1879533
UMLS CUI [2,1]
C0022885
UMLS CUI [2,2]
C1879533
UMLS CUI [3,1]
C0031809
UMLS CUI [3,2]
C1879533
able and willing to follow contraception requirements
Descrizione

Contraceptive methods Willing

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
able to read and understand, and willing to sign the informed consent form and abide by the study restrictions.
Descrizione

Informed Consent | Protocol Compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject has any contraindications to pegasys® or copegus® therapy
Descrizione

Medical contraindication Pegasys | Medical contraindication Copegus

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1176430
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C1170183
evidence of hepatic decompensation in cirrhotic subjects
Descrizione

Hepatic decompensation | Subject Cirrhotic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1394798
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0439686
history of organ transplant
Descrizione

Organ Transplantation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0029216
history of, or any current medical condition which could impact the safety of the subject in participation in the study
Descrizione

Medical condition Impact Patient safety

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C4049986
UMLS CUI [1,3]
C1113679

Similar models

Eligibility Hepatitis C NCT00758043

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis C untreated | Pharmaceutical Preparations Absent | Investigational New Drugs Absent | Pharmacotherapy Absent
Item
has not received any previous treatment with any approved or investigational drug or drug regimen for the treatment of hepatitis c
boolean
C0019196 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0013230 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0013216 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Age
Item
male and female subjects, 18 to 70 years of age, inclusive
boolean
C0001779 (UMLS CUI [1])
Hepatitis C virus genotype determination | Hepatitis C, Chronic | HCV RNA Detectable
Item
genotype 1, chronic hepatitis c with detectable hcv rna.
boolean
C1533728 (UMLS CUI [1])
C0524910 (UMLS CUI [2])
C0369335 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
Laboratory Results Acceptable | Laboratory Procedures Acceptable | Physical Examination Acceptable
Item
screening laboratory values, tests, and physical exam within acceptable ranges
boolean
C1254595 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
C0022885 (UMLS CUI [2,1])
C1879533 (UMLS CUI [2,2])
C0031809 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Contraceptive methods Willing
Item
able and willing to follow contraception requirements
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Informed Consent | Protocol Compliance
Item
able to read and understand, and willing to sign the informed consent form and abide by the study restrictions.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Pegasys | Medical contraindication Copegus
Item
subject has any contraindications to pegasys® or copegus® therapy
boolean
C1301624 (UMLS CUI [1,1])
C1176430 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1170183 (UMLS CUI [2,2])
Hepatic decompensation | Subject Cirrhotic
Item
evidence of hepatic decompensation in cirrhotic subjects
boolean
C1394798 (UMLS CUI [1])
C0681850 (UMLS CUI [2,1])
C0439686 (UMLS CUI [2,2])
Organ Transplantation
Item
history of organ transplant
boolean
C0029216 (UMLS CUI [1])
Medical condition Impact Patient safety
Item
history of, or any current medical condition which could impact the safety of the subject in participation in the study
boolean
C3843040 (UMLS CUI [1,1])
C4049986 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial